Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Parallel Group Controlled Comparison Study of Clevidipine Versus Placebo or Standard of Care for Dyspnea and Blood Pressure Control in Acute Heart Failure (PRONTO II)

NCT04592380 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT04592380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04592380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Parallel Group Controlled Comparison Study of Clevidipine Versus Placebo or Standard of Care for Dyspnea and Blood Pressure Control in Acute Heart Failure (PRONTO II)
Lead sponsor
The Medicines Company
Phase
Phase 3
Overall status
Withdrawn
Start date
August 31, 2014
Completion date
November 30, 2016
Enrollment
0 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure, dyspnea, hypertension